📰 Mployee Wellness Programs News
Page 22 - Mployee Wellness Programs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mployee Wellness Programs. Real-time updates on events, politics, business and more.
January 23, 2024
Turquoise Health closed a $30 million Series B round, which brings its total funding to date to $55 million. The San Diego-based startup, which has more than 160 customers, sells a platform that makes it easier for hospitals and payers to comply with price transparency regulations.
January 23, 2024
In 2024, the weight loss market finds itself at a crossroads, grappling with pivotal questions that will shape the future. The winners will prioritize affordable lifelong care, scalable coaching and support, and a diverse set of solutions that give people second and third chances along their weight loss journeys.
January 23, 2024
Sanofi is acquiring Inhibrx to get its hands on a drug candidate in pivotal testing for the protein deficiency alpha-1 antitrypsin deficiency, which leads to lung and liver problems. Inhibrx’s remaining assets will be spun out into a new company.
January 22, 2024
Adoption of value-based care has been slower in rural communities. With many rural providers struggling to even stay afloat, it can be difficult to switch to value-based care, according to one healthcare executive.
January 22, 2024
No matter the outcome, it’s certain that the cost of drugs will not be an issue easily resolved anytime soon even though several other states also have laws allowing for drug imports.
January 22, 2024
Exceptional awareness levels help hospitals improve operational efficiency and can also help health systems increase capacity, improve access to care, achieve higher profitability and improve margins.
January 22, 2024
In its Phase 3 test, Ionis Pharmaceuticals drug donidalorsen reduced the frequency of swelling attacks caused by the rare disease hereditary angioedema. If Ionis can commercialize this drug, competition would include products from Takeda Pharmaceutical and BioCryst Pharmaceuticals.
January 21, 2024
The FDA said Amgen’s Prolia may lead to low levels of calcium, or hypocalcemia. The osteoporosis drug’s black box warning follows an FDA review of Centers for Medicare & Medicaid Services studies that found Prolia led to a significant increase in the risk of severe hypocalcemia compared to treatment with an older class of medicines.
January 21, 2024
Here are the key trends that will need to be top of mind for provider organizations that are transitioning to VBC, or looking to improve their performance under value-based contracts.
January 21, 2024
During a recent webinar, industry leaders agreed that virtual-first health plans have significant potential to cut costs and improve members’ experiences — if executed well. They also noted that employers are more willing than ever to adopt these types of plans.